The market wont matter with a big deal, fda approval, or outstanding results. Cancer treatment saves lives. If the data/deal is good enough the sp will reflect regardless of market conditions. I am hoping for a billion dollar deal with merck and continue separately to develop efti stand alone. IMP761 also has multi billion dollar potential for overactive immune systems.
j
Ann: Immutep to announce new TACTI-002 data at ASCO 2022, page-19
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $480.0M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.5¢ | 32.0¢ | $1.703M | 5.215M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 211685 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 279000 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |